Goldman Sachs Downgrades Walgreen (WAG) to Buy, Less Upside Potential
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- SK Hynix’s record plunge drags down global chip stocks
- Oil up 9% to one-month high as US says it will blockade entire Iranian coastline, all vessels
- Ditching streaming could boost Disney stock by 40%, Wells Fargo says
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
Citi Upgrades Walgreen (WAG) from Sell to Buy
March 20, 2013 8:00 AM EDTCiti upgraded Walgreen (NYSE: WAG) from Sell to Buy.
For an analyst ratings summary and ratings history on Walgreen click here. For more ratings news on Walgreen click here.
Shares of Walgreen closed at $44.74 yesterday, with a 52 week range of $28.53-$45.80.... More
JPMorgan Upgrades Walgreen (WAG) to Overweight
March 20, 2013 7:02 AM EDTJPMorgan upgraded Walgreen (NYSE: WAG) from Neutral to Overweight with a price target of $55.00 (from $41.00).
For an analyst ratings summary and ratings history on Walgreen click here. For more ratings news on Walgreen click here.
Shares of Walgreen closed at $44.74 yesterday, with a 52 week range of $28.53-$45.80.... More
With Walgreen (WAG) Deal in Bag, AmerisourceBergen (ABC) Could Be Takeout Target
March 19, 2013 10:06 AM EDTThis morning Walgreen Company (NYSE: WAG) and Alliance Boots GmbH entered into a long-term partnership with AmerisourceBergen (NYSE: ABC) meant to reduce costs and increasing patient access to pharmaceuticals. From an investors perceptive, the deal may lay the the... More
Cardinal Health (CAH) Slammed as AmerisourceBergen Steals Walgreen (WAG) Contract
March 19, 2013 8:47 AM EDTCardinal Health, Inc. (NYSE: CAH) is sharply lower early Tuesday after rival AmerisourceBergen (NYSE: ABC) won the Walgreen (NYSE: WAG), and Alliance Boots GmbH contract.
Walgreen accounted for approximately 21 percent of Cardinal Health's... More
UPDATE: Walgreen Company (WAG) Tops Q2 EPS by 2c; Front-End Comps Down 2.6%
March 19, 2013 6:36 AM EDT(Updated - March 19, 2013 8:21 AM EDT)
Walgreen Company (NYSE: WAG) reported Q2 EPS of $0.96, $0.02 better than the analyst estimate of $0.94. Revenue for the quarter came in at $18.65 billion versus the consensus estimate of $18.72 billion.
Front-end comparable store sales (those open at least a year) decreased 2.6 percent in the second quarter, customer traffic in comparable stores... More
